Advertisement
The Lancet Infectious Diseases

About The Lancet Infectious Diseases

About the journal

The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.

Reputation and Impact

The Lancet Infectious Diseases has an Impact Factor of 24.446® and ranks first among infectious diseases journals (2019 Journal Citation Reports®, Clarivate Analytics 2020). The Lancet Infectious Diseases is recognised for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering such areas as the treatment and research of HIV/AIDS, antibiotic resistance, emerging infections, and public health.

Information for Authors

The Lancet Infectious Diseases considers any original research contribution that advocates change in or illuminates infectious disease clinical practice and informative reviews on any topic connected with infectious diseases. Because the journal has an international readership from a wide range of specialties, it is vital that articles should be written clearly and should not assume a level of knowledge above that of, say, a reasonably well-read, recently qualified, doctor in training. One way to find out if your article is understandable to those reading outside their immediate field of interest is to show the manuscript to colleagues in other specialties. If they find it difficult to follow, so will a good proportion of the readership. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. Further details on the different sections of The Lancet Infectious Diseases, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email [email protected]).

The journal publishes a range of article types that encompass all aspects of infectious diseases and medicine:, Newsdesk, Media Watch, Comment, Correspondence, Original Research, Review, Historical Review, Personal View, Grand Round, and Clinical Picture.

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Manuscript submission

To submit your manuscript to The Lancet Infectious Diseases please visit : http://www.editorialmanager.com/thelancetid

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About our content

The aim of The Lancet Infectious Diseases is to publish interesting and informative research articles and reviews on any topic connected with infectious diseases and human health. Our preference is to publish articles likely to influence clinical practice or thinking. Topics include, but are not limited to:

  • Anti-infective therapy and immunisation
  • Bacterial, viral, fungal, and parasitic infections
  • Emerging infectious diseases
  • HIV/AIDS, malaria, and tuberculosis and mycobacterial infections
  • Infection control
  • Infectious diseases epidemiology
  • Neglected tropical diseases and travel medicine

About the Editorial team

John McConnell is the Editor-in-Chief. He studied clinical microbiology and parasitology at the University of East London, before spending 6 years researching septic-shock-related topics at the Royal Postgraduate Medical School, Hammersmith Hospital, London (now part of Imperial College London). He joined The Lancet in 1990, and was a peer-review editor before becoming the first editor of the journal’s website in 1996. In 2001, John McConnell was the founding editor of The Lancet Infectious Diseases. He has been a member of the organising committee of numerous conferences, and has appeared as an expert commentator on BBC, ITV, Channel 4, Sky News, Al Jazeera, CNBC, CNN, and CCTV America.

Marco De Ambrogi is a Senior Editor. He studied veterinary medicine at the University of Parma, in Italy, then completed a PhD in endocrinology at the University of Bologna. After several postdoctoral positions at the Royal Veterinary College in London, UK, Marco moved to publishing working first as Editorial Assistant at BioMed Central, then as Associate Editor at Future Medicine and after a span as Medical Writer at Imperial College, he joined Elsevier as Senior Editor for The Lancet Infectious Diseases in 2014. His main interests are parasitology, zoonoses, tropical medicine, and global health and what he enjoys most of his work is the daily contact with people from all parts of the world.

Phoebe Hall

Phoebe Hall is a Senior Editor. She studied biology at the University of Exeter before joining Spandidos Publications as a Copy Editor in 2015. She joined The Lancet as an Assistant Editor in 2016 and became Senior Editor at The Lancet Infectious Diseases in 2019. Her main interests are diagnostics, therapeutics, and public health.

Lucy Sheytanova

Ludmila (Lucy) Sheytanova is a Senior Editor. She graduated from the University of St Andrews in 2014 with a BSc (Hons) in biology with Arabic. She then completed a PhD in cell and molecular mechanisms of Alzheimer’s disease at University College London before joining The Lancet as an Assistant Editor in 2018. In 2020, she became Senior Editor for The Lancet Infectious Diseases. She is interested in antimicrobial resistance, global health and health policy, and vector-borne diseases, and she also maintains an interest in neurodegeneration.

International Advisory Board

The International Advisory Board of The Lancet Infectious Diseases consists of key opinion leaders and researchers who lend their expertise to this journal. We are very grateful for their support and advice on editorial matters.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

November 2020
Volume 20, Issue 11